You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inverse Agonist

Showing 1 - 25 of 1,881
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alcohol Use Disorder, Alcohol Drinking Trial in Boston (Pitolisant, Placebo)

Recruiting
  • Alcohol Use Disorder
  • Alcohol Drinking
  • Boston, Massachusetts
    Boston University Psychiatry Research Center, Clinical Studies U
Dec 24, 2022

Active Ethanol and Active Iomazenil, Active Ethanol and Placebo Iomazenil, Placebo Ethanol and Placebo Iomazenil Trial in West

Active, not recruiting
  • Active Ethanol and Active Iomazenil
  • +3 more
  • West Haven, Connecticut
  • +1 more
Oct 12, 2021

Parkinson Disease Trial in France (drug, behavioral, procedure)

Recruiting
  • Parkinson Disease
  • Active drug: pimavanserin 17mg (2 strength tablets)
  • +9 more
  • Besançon, France
  • +15 more
Jan 20, 2022

Carcinoma, Hepatocellular Trial in Houston (Meclizine Oral Tablet)

Recruiting
  • Carcinoma, Hepatocellular
  • Meclizine Oral Tablet
  • Houston, Texas
  • +4 more
Sep 28, 2021

Autism Spectrum Disorder Trial (Pitolisant, Placebo)

Not yet recruiting
  • Autism Spectrum Disorder
  • (no location specified)
Jul 12, 2023

Excessive Daytime Sleepiness Trial (Pitolisant, Placebo oral tablet)

Recruiting
  • Excessive Daytime Sleepiness
  • Beijing, China
    Tsinghua Changgung Hospital
Oct 17, 2022

Plaque Psoriasis Trial in United States (AUR101, Placebo)

Completed
  • Plaque Psoriasis
  • Fort Smith, Arkansas
  • +24 more
Dec 11, 2022

Stem Cell Transplant Complications Trial in Edmonton (Loratadine, Placebo)

Not yet recruiting
  • Stem Cell Transplant Complications
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jun 13, 2022

Kidney Diseases, Diabetic Nephropathies, Diabetes Complications Trial in San Antonio (GFB-024, Placebo)

Completed
  • Kidney Diseases
  • +4 more
  • San Antonio, Texas
    Worldwide Clinical Trials
Mar 24, 2022

Tobacco Use, Tobacco Smoking, Tobacco Dependence Trial (300 mg Cannabidiol, 600 mg Cannabidiol, Placebo)

Recruiting
  • Tobacco Use
  • +4 more
  • 300 mg Cannabidiol
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Behavioral Pharmacology Research Unit
Nov 22, 2022

Intermittent Explosive Disorder Trial in Columbus (Pimavanserin 34 mg, Placebo)

Not yet recruiting
  • Intermittent Explosive Disorder
  • Pimavanserin 34 mg
  • Placebo
  • Columbus, Ohio
    The Ohio State University College of Medicine
May 31, 2023

Panic Disorder Trial in Leiden (CVL-865 High dose, Alprazolam 1mg XR, Placebo)

Completed
  • Panic Disorder
  • CVL-865 High dose
  • +3 more
  • Leiden, Zernikedreef 8, Netherlands
    Centre for Human Drug Research
Jan 10, 2022

Alcoholism Trial run by the NIAAA (PF-05190457, Placebo)

Terminated
Has Results
  • Alcoholism
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 23, 2022

Ovarian Cyst Simple Trial (norethisterone acetate)

Not yet recruiting
  • Ovarian Cyst Simple
  • norethisterone acetate
  • (no location specified)
Mar 19, 2022

Second-line Therapies for Type 2 Diabetes and Moderate

Enrolling by invitation
  • Type 2 Diabetes
  • Cardiac Disease
  • Glucagon like peptide 1 receptor agonist
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic Rochester
Jan 26, 2022

Ovarian Stimulation, Human Chorionic Gonadotropin, Oocyte Donors Trial in Thessaloniki (Dual trigger (human chorionic

Recruiting
  • Ovarian Stimulation
  • +2 more
  • Dual trigger (human chorionic gonadotropin plus GnRH-agonist)
  • GnRH-agonist only trigger
  • Thessaloniki, Greece
    Embryolab Fertility Clinic
Nov 20, 2023

Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)

Completed
  • Hair Diseases
  • +2 more
  • DA-OTC-002
  • Manaus, Brazil
    Hospital Oscar Nicolau
Oct 20, 2023

Knee Arthroplasty, Total Trial (Optetrak Logic CR Knee System)

Not yet recruiting
  • Knee Arthroplasty, Total
  • Optetrak Logic CR Knee System
  • (no location specified)
Aug 23, 2022

Semaglutide Use in Acute Pulmonary Embolism

Completed
  • Pulmonary Embolism
  • London, United Kingdom
    Colm McCabe
Nov 3, 2023

Healthy Subjects, Hyperalgesia, Inflammations, Endodontic Trial in Copenhagen (Naloxone, Normal Saline)

Recruiting
  • Healthy Subjects
  • +4 more
  • Copenhagen, Denmark
    Neuroscience Center, Copenhagen University Hospital
Feb 11, 2022

Type 2 Diabetes, Diabetes, Type 2 Trial (Tirzepatide)

Not yet recruiting
  • Type 2 Diabetes
  • Diabetes Mellitus, Type 2
  • (no location specified)
Feb 6, 2023

Arterial Stiffness, Hypertension, Cardiovascular Diseases Trial in Prague (Cardiovascular fitness)

Active, not recruiting
  • Arterial Stiffness
  • +2 more
  • Cardiovascular fitness
  • Prague, Czechia
  • +1 more
Sep 14, 2023

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • Duarte, California
  • +12 more
Sep 21, 2022

Exercise Performance Trial in Copenhagen (Indacaterol and Mometasonefluroate (low dose), Placebo, Indacaterol and

Recruiting
  • Exercise Performance
  • Indacaterol and Mometasonefluroate (low dose)
  • +2 more
  • Copenhagen, Denmark
    August Krogh Building
Oct 4, 2023

Incidence of Retained Gastric Food on Endoscopy

Not yet recruiting
  • Gastric Content Aspiration
  • Esophagogastroduodenoscopy
  • (no location specified)
May 16, 2023